A New Collection of Well being Insights Is on the Manner
IMPORTANT
A New Collection of Well being Insights Is on the Manner
Our workforce has been working behind the scenes to organize new analysis and sensible well being methods for our readers. Whereas we end getting ready what’s coming subsequent, we invite you to discover one of many most-read articles from our library under. See precisely what’s altering →
Medication is strongly biased in the direction of adopting biochemical fashions of illness as this facilitates expensive therapeutics being developed for every illness and therefore sustains the medical trade. Sadly, in lots of instances, the biochemical strategy to illness, at finest, can handle signs, and because of this, many situations stay “incurable” whereas non-patentable pure therapies that may treatment them languish in obscurity.
That’s why, regardless of spending an ever growing sum of money on Alzheimer’s analysis (e.g., the NIH spent 2.9 billion in 2020 and three.9 billion in 20241), we’ve nonetheless didn’t make any actual progress on the illness. That is significantly exceptional given the huge prices to the nation (e.g., final 12 months Alzheimer’s was estimated to price the USA 360 billion {dollars}2) and the even higher social prices that accompany it.
The Amyloid Juggernaut
In 1906, plaques (of amyloid) within the mind had been recognized as the reason for Alzheimer’s illness. Because the years have passed by, the vast majority of analysis for treating Alzheimer’s illness has been focused at eliminating these plaques. Sadly, to cite a 2022 article:3
“A whole bunch of medical trials of amyloid-targeted therapies have yielded few glimmers of promise, nonetheless; solely the underwhelming Aduhelm has gained FDA approval. But Aβ nonetheless dominates analysis and drug growth. NIH spent about $1.6 billion on initiatives that point out amyloids on this fiscal 12 months, about half its general Alzheimer’s funding.
Scientists who advance different potential Alzheimer’s causes, akin to immune dysfunction or irritation, complain they’ve been sidelined by the ‘amyloid mafia.’ Forsayeth says the amyloid speculation turned ‘the scientific equal of the Ptolemaic mannequin of the Photo voltaic System,’ during which the Solar and planets rotate round Earth.”
Notice: Often, when a defective paradigm fails to elucidate the illness it claims to handle, quite than admit the paradigm is flawed, its adherents will label every conflicting piece of proof as a paradox (e.g., the French “paradox” disproves the notion ldl cholesterol causes coronary heart illness4) and dig deeper and deeper till they’ll discover one thing to proceed propping up their ideology (e.g., ldl cholesterol decreasing statins present virtually no profit for coronary heart illness whereas having important uncomfortable side effects but proceed being pushed on sufferers).
The constant failure of the amyloid mannequin to treatment Alzheimer’s step by step invited growing skepticism in the direction of it, which resulted in increasingly scientists finding out various fashions of the illness. Earlier than lengthy, they discovered different components performed a much more important function in inflicting the illness (e.g., persistent irritation), and by 2006, this angle appeared poised to vary the path of Alzheimer’s analysis.
In response, the amyloid proponents pivoted to defending their failed speculation was due to not amyloid clumps, however quite poisonous elements of it (oligomers) and a Nature 2006 paper appeared which recognized a beforehand unknown poisonous oligomer, Aβ*56, and supplied proof that it induced dementia in rats.5
This paper cemented each the amyloid beta and poisonous oligomer hypotheses (because it supplied the proof many adherents to the speculation had been ready for) and quickly turned probably the most cited works within the subject of Alzheimer’s analysis. Its authors rose to tutorial stardom, produced additional papers validating their preliminary speculation, and billions extra had been invested by each the NIH and the pharmaceutical trade in analysis of the amyloid and poisonous oligomer speculation.
It ought to be famous that some had been skeptical of their findings and likewise had been unable to duplicate this information, however not often had a voice within the debate:
“The spotty proof that Aβ*56 performs a task in Alzheimer’s had [long] raised eyebrows.6 Wilcock has lengthy doubted research that declare to make use of ‘purified’ Aβ*56. Such oligomers are notoriously unstable, changing to different oligomer sorts spontaneously. A number of sorts will be current in a pattern even after purification efforts, making it arduous to say any cognitive results are because of Aβ*56 alone, she notes — assuming it exists.
In actual fact, Wilcock and others say, a number of labs have tried and failed to search out Aβ*56, though few have printed these findings. Journals are sometimes tired of adverse outcomes, and researchers will be reluctant to contradict a well-known investigator.”
The Amyloid Scandal
On the finish of 2021, a neuroscientist doctor was employed by buyers to guage an experimental Alzheimer’s drug and found indicators that its information consisted of doctored Western Blots (and due to this fact misguided assessments of what oligomers had been current inside analysis topics’ brains).7 As he explored the subject additional, he found different papers inside the Alzheimer’s literature had been flagged for holding doctored Western Blots.
Notice: Western blots, used to check for proteins, are one of many few simply detectable types of analysis fraud (e.g., we found Pfizer submitted faux Western blots to regulators to “show” their vaccine labored). Regrettably, way more undetectable fraud exists all through the scientific literature (e.g., unbiased researchers evaluating regulatory submissions found Pfizer additionally submitted doctored information on the place the COVID vaccine is distributed within the physique8).
Earlier than lengthy, the neuroscientist observed three of these suspect papers had been printed by the identical creator and determined to analyze the creator’s different publications. This led him to the seminal 2006 Alzheimer’s publication, which contained clear indicators of fraud.9
As investigation then uncovered 20 doctored papers written by the creator, 10 of which pertained to Aβ*56 (together with a co-researcher testifying to earlier scientific misconduct by the creator).
The Amyloid Business
One of many exceptional issues about this monumental fraud was how little was achieved about it. For instance, the NIH was notified in January 2022, but in Could 2022, past nothing being achieved, the NIH gave the suspect researcher a coveted $764,792 analysis grant (signed off by one other one of many authors of the 2006 paper10).
In July 2022, Science printed an article exposing the incident and the clear fraud that had occurred.11 Regardless of this, the researcher was allowed to stay in his place as a tenured medical faculty professor.12 It was not till June 2024 that the 2006 article was retracted on the request of the authors13 — all of whom denied being at fault and insisted the doctored pictures had not affected the article’s conclusions.
Finally, on January 29, 2025, throughout his affirmation listening to, RFK cited the paper for example of the institutional fraud and wasted tax {dollars} inside the NIH, and some days later, the suspect researcher introduced his resignation from the medical faculty professorship (whereas nonetheless sustaining his innocence).14
This odd habits (e.g., the medical subject continues to insist the confirmed fraud has not disproven the Amyloid speculation) seemingly outcomes from how a lot cash is at stake — past the analysis {dollars}, roughly 7 million adults have Alzheimer’s — equating to a whole lot of billions in potential (Medicare funded) gross sales annually.15
The Failed Amyloid Medicine
Lately, a monoclonal antibody that made immune cells goal amyloid demonstrated restricted success in treating Alzheimer’s — which was embraced as revolutionary by the medical neighborhood, the pharmaceutical trade, and drug regulators. In flip, the primary new drug obtained accelerated approval (which the FDA proudly introduced).16 The second then obtained a quiet backdoor approval (because of the immense controversy surrounding the primary),17 and the third was partially authorized a 12 months and a half later.18
Every year, JP Morgan (Chase Financial institution) hosts a non-public convention for pharmaceutical buyers that units the tone for the whole trade. In 2023, its focus (lined intimately right here) was on the unimaginable profitability of the brand new Alzheimer’s medication and the GLP-1s like Ozempic (which the FDA has additionally relentlessly promoted). Most remarkably, the (extensively considered as corrupt) FDA commissioner was a keynote speaker, and some days earlier than the convention, had enacted the second backdoor approval.
Nonetheless, regardless of the rosy footage painted across the medication (which every attacked completely different facets of amyloids), they had been extremely controversial as:
• The FDA’s unbiased advisory panel, in a really uncommon transfer, voted 10-0 (with one abstaining) in opposition to approving Aduhelm, the primary amyloid drug (which focused amyloid plaques), however the FDA authorized it anyhow. In a extremely unprecedented transfer, three of the advisors then resigned, calling it “most likely the worst drug approval determination in current U.S. historical past.”19
• That drug was priced at $56,000 a 12 months — making it ample to bankrupt Medicare, (which attracted a Congressional investigation).20
• Mind swelling or mind bleeding was present in 41% of sufferers enrolled in its research.21 Moreover, complications (together with migraines and occipital neuralgia), falls, diarrhea, confusion, and delirium had been additionally notably elevated in comparison with placebo.
• No enchancment in Alzheimer’s was famous; quite one evaluation discovered it slowed the development of Alzheimer’s by 20% (though this might have been a protocol artifact quite than an actual impact).
The second monoclonal antibody (which focused amyloid precursors) had a considerably higher danger profit profile22 (solely 21% skilled mind bleeding and swelling because of decreased concentrating on of steady amyloid plaques), and 26.4% discount within the development of Alzheimer’s was detected within the trial (which for context, translated to a 0.45 discount on a scale the place a discount of at the least 1 to 2 factors is required to create an affect which is in any means significant for a affected person).
The third monoclonal (which focused amyloid plaques considered extra pathologic)23 was additionally contested because it induced 36.8% of recipients to develop mind bleeding or swelling, like the opposite amyloid drugs, continuously induced complications and infusion reactions (e.g., nausea, vomiting, modifications in blood strain, allergies, or anaphylaxis) and there have been causes to suspect the trial had vastly overstated its minimal advantages.
Remarkably, regardless of widespread protest in opposition to the third drug, the FDA’s new advisory panel voted unanimously in favor of it, though it had a really related mechanism, efficacy, and toxicity to the beforehand unanimously rejected amyloid drug.
It ought to due to this fact come as no shock that, when the British Medical Journal performed an unbiased investigation, it discovered that, inside publicly out there databases, 9 out of 9 (assessable) members of the advisory committee had important monetary conflicts of curiosity.24
Happily, regardless of the aggressive promotion of amyloid medication and the trade’s finest makes an attempt to advertise the sector, the market considerably acknowledged how dangerous they had been. The primary drug had its worth halved (then was withdrawn as nobody wished it — making round 5 million {dollars} complete),25 whereas the opposite two have had very modest gross sales (e.g., 290 million for the most well-liked one26).
What Amyloids Medicine Present Us
From this, 4 issues stand out:
• These medication persistently injury mind tissue, indicating that their mechanism of motion was inherently harmful (e.g., it creates mind swelling by inflicting immune cells attacking amyloid additionally to assault mind tissue, or it creates mind bleeding by eradicating amyloid plaque that patches vessel partitions and stabilizes mind tissue). Remarkably, regardless of this difficulty being acknowledged, it has not deterred the utilization of those class medication.
• Eradicating amyloid gives minimal profit and could also be counterproductive. In actual fact, one of many solely protocols that has had confirmed success in treating Alzheimer’s as a substitute views amyloid as a protecting mechanism the mind makes use of to stop additional injury.
• A completely absurd quantity of time and money has been wasted on this endeavor because of the medical subject’s have to discover a patentable drug.
• The give attention to these profitable medication has diverted consideration from different (off-patent) therapies which can be extra seemingly to assist Alzheimer’s sufferers.
For instance, a randomized managed trial which gave MCTs derived from coconut discovered that over 6 months,27 80% remained steady or improved — which for context, is healthier than what any of the amyloid drug trials confirmed, and extra importantly, doesn’t trigger mind bleeds (and prices loads lower than the annual tough $30,000 price for these medication).
Notice: Quite a few readers have shared that coconut oil improved their relative’s dementia.
Likewise, only a few are conscious of a 2022 examine that ought to have revolutionized the whole Alzheimer’s subject:28
Notice: The RECODE protocol was primarily based round figuring out the underlying explanation for a affected person’s cognitive impairment (as 5 various things may cause dementia), after which offering applicable pure therapies to handle the relevant trigger. Since then, many others have replicated its success of their sufferers.
DMSO and Dementia
Dimethyl Sulfoxide (DMSO) is a naturally occurring compound that has a wide range of distinctive therapeutic properties that permit it to rescue tissues from dying and revive these broken from earlier accidents — finest demonstrated by a long time of proof displaying DMSO can heal strokes, mind bleeds, extreme concussions, and spinal wire accidents and save sufferers from a lifetime of paralysis.
As lots of DMSO’s mechanisms immediately counteract the processes that set off dementia, I’ve obtained many accounts like these from readers:
“My uncle’s spouse has dementia and has been unable to talk for over a 12 months. My mother lately visited them and advised them about DMSO. He started to provide his spouse DMSO orally. After two weeks she started to speak once more.29
I learn the article and commenced giving it to my 93 12 months previous mom in her juice each morning on the finish of November. She has had some type of dementia for over 15 years. Since taking the DMSO, she now not suffers with extreme sundowners. She is extra ‘with it’ and might talk and snigger with us. Her persona is again. She is crossing her legs once more and lifting her pinky finger when consuming her espresso. It’s quite a lot of little issues that make a distinction.
She is ready to perceive when I’m asking her to make use of the lavatory. She is extra cognitive and has began coloring in her coloring books once more.30
I deeply respect your posts on DMSO. You helped convey spontaneous interplay again into the lifetime of my father with Alzheimer’s.”31
Quite a few research assist these experiences:
• When rats had their carotid arteries surgically modified to scale back the blood going to the mind, DMSO prevented each the neuronal injury and the numerous lack of spatial reminiscence and studying that in any other case occurred.32
• In an analogous examine, rats who developed persistent and extreme reminiscence impairment from decreased mind blood stream obtained DMSO and FDP for 7 days, which improved their reminiscence by 54%, almost reaching the cognitive operate rats whose blood stream was by no means reduce off.33,34
• In rats, each day DMSO counteracted reminiscence impairment induced by intracerebroventricular STZ infusions,35 whereas in an analogous examine,36 DMSO and Ginkgo biloba improved studying and reminiscence in rats given Alzheimer’s illness.
• Consuming minute quantities of DMSO prevented the visible degeneration in any other case seen in rats engineered to have early Alzheimer’s illness.37 In one other examine of these rats, it protected key mind cells from disappearing and enhanced each their spatial reminiscence and scent (whereas lowering their anxiousness).38 Likewise, in rats bred to develop cerebellar issues, DMSO prevented age-related deterioration of sure cognitive features (e.g., reminiscence and spatial studying).
These outcomes have additionally been replicated in people:
• In 18 sufferers with possible Alzheimer’s after three months, DMSO vastly improved reminiscence, focus, and communication, alongside a major lower in disorientation in time and area.39
• In 104 aged adults with dementia because of cerebrovascular ailments, concussions, or Parkinson’s, DMSO mixed with amino acids considerably improved their cognition and motor operate.40
• In 100 sufferers with cerebrovascular ailments (lots of whom had dementia),41 DMSO induced virtually all to have their cardiovascular parameters enhance and:
“Restoration from the final signs was optimistic; there have been favorable modifications which had been mirrored in a sense of properly being, the restoration of agility, modifications of temper from depressed to homosexual, enchancment of sleeping, and clearer speech. As regards the ‘focal’ outcomes, accelerated restoration from hemiplegia and hemiparesia was registered. A speedier restoration of speech in instances of outlined or indicated aphasia befell.”
Conclusion
The Alzheimer’s story illustrates how medical science’s relentless give attention to commercializable merchandise has failed the nation. This should be changed with prioritizing understanding the basis causes of the persistent sicknesses we face.
Happily, now that MAHA can set nationwide well being coverage and unbiased media has damaged the media’s monopoly over the reality because of the lies we noticed all through COVID-19, increasingly are stepping exterior the medical orthodoxy to pursue therapies that may really heal them. A chance like this has by no means existed earlier than, and it’s vital every of us brings consideration to the necessity for actual medication earlier than the window to basically change the follow of drugs closes.
Creator’s Notice: That is an abridged model of an extended article which discusses the precise causes and coverings for Alzheimer’s illness and the cognitive decline which precedes it. That article, together with extra hyperlinks and references, will be learn right here. Moreover, a companion article on how DMSO treats neurological accidents (e.g., strokes, mind hemorrhages, traumatic mind accidents, spinal paralysis, and developmental delay) will be learn right here.
A Notice from Dr. Mercola In regards to the Creator
A Midwestern Physician (AMD) is a board-certified doctor from the Midwest and a longtime reader of Mercola.com. I respect AMD’s distinctive perception on a variety of matters and am grateful to share it. I additionally respect AMD’s want to stay nameless since AMD remains to be on the entrance strains treating sufferers. To seek out extra of AMD’s work, make sure you try The Forgotten Facet of Medication on Substack.
